FuzeHub Awards $10,000 Grant to Innosek to Ramp Up Manufacturing of Face Shields to Fight COVID-19

Page Views: 228
Fuzehub Awards $10,000 Grant To Innosek To Ramp Up Manufacturing Of Face Shields To Fight Covid-19

 

FuzeHub, the statewide center for the New York Manufacturing Extension Partnership (NY MEP), has awarded about $10,000 in grant funding to Innosek, a Western New York-based advanced manufacturing company, to help it expand and accelerate its production of face shields, which are urgently needed to combat the spread of COVID-19.

“New York’s manufacturers have taken action to support the fight against the coronavirus, pivoting production or scaling up operations to produce supplies that keep our communities safe and healthy. Among them, Innosek has stepped up to help in a big way,” said FuzeHub Executive Director Elena Garuc.

“This grant award will help Innosek contribute to the fight against COVID-19 now — and as we look to the future, it will support the state’s economic resiliency by strengthening an emerging manufacturing company and equipping it for sustained growth,” said Everton H. Henriques, NY MEP Solutions Director for FuzeHub.

Innosek specializes in additive manufacturing. It uses 3D printing technology to produce components and supplies for several industry sectors, including defense, automotive, electronics, telecommunications and healthcare.

It pivoted the focus of its team to produce face shields for hospitals and other health care facilities. Innosek uses its 3D printers to produce the frames for face shields and then assembles the full unit with transparent sheets and elastic bands. It has earned contracts from significant national and regional healthcare institutions to fulfill their increased need for face shields.

Meanwhile, the company has also had to ramp up production for several of its existing clients that have experienced supply chain disruptions as a result of the global outbreak.

“With our systems at full capacity and our team stretched, we turned to FuzeHub for help,” said Innosek’s Co-founder & Production Manager, John Kappel. “This grant funding will help us rapidly increase production to meet the demand for essential supplies at the frontlines of the coronavirus pandemic. It will also contribute to our long-term success. After seeing how quickly additive manufacturers like Innosek have pivoted or increased production, more manufacturers will likely choose to incorporate 3D printing and other additive technologies into their supply chains. We’ll be ready to help.”

FuzeHub’s $10,000 grant will help fund the purchase and modification of nine additional 3D printing units as well as materials needed to produce face shields. The expansion will allow Innosek to increase its weekly production of face shields by about 40 percent – from about 1,100 to 1,500 units.

Innosek recently moved to a larger facility in Tonawanda, providing the necessary space to expand. Previously a six-employee enterprise, the company has had to essentially double its workforce, bringing in six more temporary workers to fill current needs. It hopes to retain these workers if orders remain at current levels.

FuzeHub helps New York manufacturers navigate the state’s extensive network of resources, programs and partners. As the statewide NY MEP center, it collaborates with the state’s 10 regional NY MEP centers – in Western New York, Insyte Consulting is the regional center.

In addition to its COVID-19 Manufacturing Grants program designed to accelerate production of ventilators and N-95 respirators, FuzeHub has set aside a small pot of funds to support a limited number of manufacturers already engaged with FuzeHub through existing requests for assistance.

Comments

Leave a Comment

Your email address will not be published. Required fields are marked *

Exhibitor Inquiry

Attendee Request Form: 2023 Hardware Prototyping Workshop
Thanks for your interest in this resource, fill out the information below to download.

"*" indicates required fields

Hidden
This field is for validation purposes and should be left unchanged.

X
X